Cargando…

Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors

Taxanes antitumour agents such as paclitaxel and docetaxel represent a successful family of chemotherapeutic drugs. Unfortunately, acquired and innate resistance represents a clinical problem for these drugs. We investigated, on a panel of 7 human cancer cell lines, the growth inhibition effect of 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferlini, C, Distefano, M, Pignatelli, F, Lin, S, Riva, A, Bombardelli, E, Mancuso, S, Ojima, I, Scambia, G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363450/ https://www.ncbi.nlm.nih.gov/pubmed/11104578 http://dx.doi.org/10.1054/bjoc.2000.1500

Ejemplares similares

Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis.
por: Ferlini, C., et al.
Publicado: (1997)

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines
por: Ferlini, C, et al.
Publicado: (1999)

Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines
por: Engblom, P, et al.
Publicado: (1999)

IDN 5390: an oral taxane candidate for protracted treatment schedules
por: Pratesi, G, et al.
Publicado: (2003)

MDR1 causes resistance to the antitumour drug miltefosine
por: Rybczynska, M, et al.
Publicado: (2001)

Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases
por: Kruczynski, A, et al.
Publicado: (2000)

Hypersensitivity Reactions to Platinum Agents and Taxanes
por: Tsao, Lulu R., et al.
Publicado: (2021)

Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced α(1)-acid glycoprotein binding
por: Curtin, N J, et al.
Publicado: (1999)

Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft
por: Petrangolini, G, et al.
Publicado: (2004)

Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer
por: Taylor, Sarah J, et al.
Publicado: (2020)

Phase I trials of antitumour agents: fundamental concepts
por: Toloi, Diego de Araujo, et al.
Publicado: (2015)

Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity
por: Amaya, Celina, et al.
Publicado: (2022)

Beyond taxanes: the next generation of microtubule-targeting agents
por: Cortes, Javier, et al.
Publicado: (2011)

Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer Cells
por: St. George, Marc, et al.
Publicado: (2015)

DNA stretching in the nucleosome facilitates alkylation by an intercalating antitumour agent
por: Davey, Gabriela E., et al.
Publicado: (2010)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent
por: Seker, H, et al.
Publicado: (2000)

Selective cyclooxygenase inhibitors increase paclitaxel sensitivity in taxane-resistant ovarian cancer by suppressing P-glycoprotein expression
por: Lee, Jung-Pil, et al.
Publicado: (2013)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses
por: Wang, Qinghong, et al.
Publicado: (2017)

Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311
por: Burger, A M, et al.
Publicado: (1999)

Antitumour activity of peroxidases.
por: Everse, K. E., et al.
Publicado: (1985)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Caspase-2 is involved in cell death induction by taxanes in breast cancer cells
por: Jelínek, Michael, et al.
Publicado: (2013)

The role of individual caspases in cell death induction by taxanes in breast cancer cells
por: Jelínek, Michael, et al.
Publicado: (2015)

hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer
por: Ercoli, A, et al.
Publicado: (1999)

Effect of P-glycoprotein on flavopiridol sensitivity
por: Boerner, S A, et al.
Publicado: (2001)

The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
por: Evans, Jonathan P., et al.
Publicado: (2018)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
por: El-Sayed, Magda A.-A., et al.
Publicado: (2017)

Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel
por: Martinelli, M, et al.
Publicado: (2007)

Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.
por: Scambia, G., et al.
Publicado: (1990)

Inflammation of actinic keratosis with combination of alkylating and taxane agents: a case report
por: Makdsi, Fadi, et al.
Publicado: (2009)

Tin-based Antitumour Drugs
por: Gielen, Marcel
Publicado: (1994)

The realisation of targeted antitumour therapy
por: Bicknell, R
Publicado: (2005)

Antitumour Drug-Radiation Interactions
por: Carmichael, J.
Publicado: (1992)

An Overview of Antitumour Activity of Polysaccharides
por: Jin, Hongzhen, et al.
Publicado: (2022)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

A novel class of lipophilic quinazoline-based folic acid analogues: cytotoxic agents with a folate-independent locus
por: Skelton, L A, et al.
Publicado: (1999)

Inhibition of P-glycoprotein by two artemisinin derivatives
por: Steglich, Babette, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dogku4qdsq3pr8p9o4qq9u2fqj